157 related articles for article (PubMed ID: 18637078)
1. Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance.
Brant LJ; Hurrelle M; Balogun MA; Klapper P; Ramsay ME;
J Viral Hepat; 2008 Oct; 15(10):729-39. PubMed ID: 18637078
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C testing in sexual health services in England, 2002-7: results from sentinel surveillance.
Tweed E; Brant L; Hurrelle M; Klapper P; Ramsay M;
Sex Transm Infect; 2010 Apr; 86(2):126-30. PubMed ID: 19858534
[TBL] [Abstract][Full Text] [Related]
3. Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection.
Brant LJ; Hurrelle M; Balogun MA; Klapper P; Ahmad F; Boxall E; Hale A; Hollyoak V; Ibrahim IB; Irving W; Meigh R; Mutton KJ; Patel BC; Paver WK; Pugh S; Taylor C; Turner AJ; Ramsay ME
Epidemiol Infect; 2007 Apr; 135(3):417-26. PubMed ID: 16836798
[TBL] [Abstract][Full Text] [Related]
4. Failure to diagnose recent hepatitis C virus infections in London injecting drug users.
Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R
J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898
[TBL] [Abstract][Full Text] [Related]
5. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
6. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.
Judd A; Hutchinson S; Wadd S; Hickman M; Taylor A; Jones S; Parry JV; Cameron S; Rhodes T; Ahmed S; Bird S; Fox R; Renton A; Stimson GV; Goldberg D
J Viral Hepat; 2005 Nov; 12(6):655-62. PubMed ID: 16255768
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.
Roy KM; Goldberg DJ; Hutchinson S; Cameron SO; Wilson K; MacDonald L
J Med Virol; 2004 Sep; 74(1):62-6. PubMed ID: 15258969
[TBL] [Abstract][Full Text] [Related]
9. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
11. Indications of immune protection from hepatitis C infection.
Aitken CK; Bowden S; Hellard M; Crofts N
J Urban Health; 2004 Mar; 81(1):58-60. PubMed ID: 15047784
[TBL] [Abstract][Full Text] [Related]
12. Experience of hepatitis C testing among injecting drug users in Sydney, Australia.
Day CA; White B; Thein HH; Doab A; Dore GJ; Bates A; Holden J; Maher L
AIDS Care; 2008 Jan; 20(1):116-23. PubMed ID: 18278622
[TBL] [Abstract][Full Text] [Related]
13. Planning for the healthcare burden of hepatitis C infection: Hepatitis C genotypes identified in England, 2002-2007.
Brant LJ; Ramsay ME; Tweed E; Hale A; Hurrelle M; Klapper P; Ngui SL;
J Clin Virol; 2010 Jun; 48(2):115-9. PubMed ID: 20399704
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
Mohsen AH; Murad S; Easterbrook PJ
HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for hepatitis C virus infection in Inland Brazil: an analysis of pooled epidemiological sectional studies.
Souto FJ; Fontes CJ; Pignati LT; Pagliarini ME; Menezes Vda M; Martinelli Ade L; Figueiredo JF; Donadi EA; Passos AD
J Med Virol; 2012 May; 84(5):756-62. PubMed ID: 22431023
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C virus infection in children admitted to an urban hospital.
Gerner P; Wirth S; Wintermeyer P; Walz A; Jenke A
J Infect; 2006 Apr; 52(4):305-8. PubMed ID: 16473408
[TBL] [Abstract][Full Text] [Related]
18. Monitoring HIV testing in diverse healthcare settings: results from a sentinel surveillance pilot study.
Tweed E; Hale A; Hurrelle M; Smith R; Delpech V; Ruf M; Klapper P; Ramsay M; Brant L
Sex Transm Infect; 2010 Oct; 86(5):360-4. PubMed ID: 20427560
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of hepatitis C virus testing methods among injecting drug users.
White B; Day C; Thein HH; Doab A; Bates A; Holden J; van Beek I; Maher L
Drug Alcohol Rev; 2008 Nov; 27(6):666-70. PubMed ID: 19378449
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C infection among recent initiates to injecting in England 2000-2008: Is a national hepatitis C action plan making a difference?
Hope V; Parry JV; Marongui A; Ncube F
J Viral Hepat; 2012 Jan; 19(1):55-64. PubMed ID: 22187945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
